Proteflazid suppositories 3 g 10 pcs.

1 suppository contains (active ingredient) flavonoids Proteflazid, obtained from a mixture (1: 1) of the grass Deschampsia caespitosa (Herba Deschampsia caespitosa L.) and the grass Calamagrostis epigeios (Herba Calamagrostis epigeios L.) – not less than 1.8 mg.

Excipients: butylhydroxyanisole (E 320), polyethylene glycol-400, polyethylene glycol-1500, polyethylene glycol-4000, to obtain a mass of 3 g

Individual hypersensitivity to the components of the drug.

Suppositories should be used vaginally.

Suppositories should be used after hygiene procedures. Before use, remove the protective plastic packaging from the suppository. Insert the suppository deep into the vagina. After inserting the suppository, it is advisable to lie down for at least 3 hours and not have sexual intercourse for at least 8 hours. It is recommended to start treatment immediately after menstruation. At the time of menstruation, a break in treatment should be taken.

For the treatment of genital diseases caused by herpes viruses of types I and II, use one suppository once a day for 7-10 days or more until the symptoms of the disease disappear.

For the treatment of recurrent herpes infection, including in the presence of cytomegalovirus infection and Epstein-Barr infection, use one suppository once a day for 10 days. The course of treatment is carried out for 3 months (10 days each month).

In the presence of papillomavirus infection and/or herpetic infections in combination with bacterial, fungal infections, use one suppository 2 times a day for 14 days. The course of treatment is carried out for 3 months (14 days every month).

Pregnant women

During preclinical studies of the active substance of the extract of the drug “Proteflazid” toxicological, teratogenic, mutagenic, embryotoxic, fetotoxic and carcinogenic effects were not detected. It is necessary to follow the rules for prescribing medicines during pregnancy or breastfeeding, assessing the benefit / risk ratio. Use is possible only as prescribed and under the supervision of a doctor.

Children

The use of the drug “Proteflazid” in the form of suppositories in children has not been studied, therefore the drug should not be prescribed to children.

Drivers

No negative impact on the ability to engage in potentially hazardous activities requiring special attention and speed of reaction was detected.

Not described. In case of overdose, you should immediately consult a doctor for further treatment.

When using the drug, slight local itching or burning of the mucous membrane is possible, which disappear on their own and do not require discontinuation of the drug.

Hypersensitivity reactions, allergic reactions are possible.

In case of allergic or any other undesirable reactions, the use of suppositories should be suspended and a doctor should be consulted regarding further treatment tactics.

Store in the original packaging at a temperature not exceeding 25 °C, out of the reach of children. Do not freeze.

Shelf life – 2 years.